Search results for " LAB"

showing 10 items of 2393 documents

Decrease in HDV endemicity in Italy.

1997

To evaluate a possible variation in hepatitis D virus endemicity in Italy, the data from a multicentre study concerning HBsAg chronic carriers first observed in 31 liver units during 1992 were compared with the corresponding figures from a similar study performed in 1987.In both studies the methodology for the recruitment of cases was the same. The overall anti-HD prevalence in 1992 was 14.4%, a significantly lower rate than that observed in 1987 (23.4%, p0.01). The decrease significantly (p0.01) affected both males and females; it occurred in all geographical areas, although to a greater extent in northern regions. It was evident in subjects below 50 years of age, but not in subjects older…

AdultMaleHBsAgmedicine.medical_specialtyCirrhosisAdolescentEndemic DiseasesVirusRisk FactorsEpidemiologymedicinePrevalenceHumansChildHepatitis B Surface AntigensHepatologyHepatitis D virus infectionbusiness.industryClinical Laboratory TechniquesIncidence (epidemiology)Infant NewbornInfantMiddle Agedmedicine.diseaseVirologyHepatitis DItalyChild PreschoolCarrier StateFemaleViral diseaseHepatitis D virusbusinessJournal of hepatology
researchProduct

The impact of pictorial health warnings on tobacco products in smokers behaviours and knowledge: The first quasi-experimental field trial after the i…

2019

Background. The aim of the study was to evaluate in the Italian smokers, the effects of implementation of the law about Pictorial Health Warnings (PHWs) on tobacco products.Methods. A quasi-experimental longitudinal design was conducted between 2016 and 2017. The data were collected before (pre-PHW/Wave 1) and after (post-PHW/Wave 2) the implementation of the law. The adopted questionnaire included impact of advertisement (Label Impact Index, LII), quitting behavior and knowledge of tobacco related diseases.Results. 455 respondents completed both the Waves. 7.7% of smokers declared to have stopped smoking in Wave 2 and 29% of these declared the PHWs as one of the reasons to quit. The knowle…

AdultMaleHealth Knowledge Attitudes Practicehealth warningQuasi-experimental studyProduct LabelingPictorial warningsPictorial Works as TopicYoung AdultPictorial warningAdvertisingSurveys and QuestionnairesHealth labelHumansLongitudinal StudiesHealth labelsHealth warningsPracticeMotivationpictorial warnings health labels health warnings tobacco advertisement quasi-experimental studyHealth KnowledgeTobacco advertisementTobacco ProductsTobacco Use DisorderMiddle AgedItalyAttitudesFemaleSmoking CessationHealth labels; Health warnings; Pictorial warnings; Quasi-experimental study; Tobacco advertisementpictorial warnings; health labels; health warnings; tobacco advertisement; quasi-experimental studyHealth labels; Health warnings; Pictorial warnings; Quasi-experimental study; Tobacco advertisement; Adult; Advertising; Female; Health Knowledge Attitudes Practice; Humans; Italy; Longitudinal Studies; Male; Middle Aged; Motivation; Pictorial Works as Topic; Smoking Cessation; Surveys and Questionnaires; Tobacco Products; Tobacco Use Disorder; Young Adult; Product Labeling
researchProduct

Outcome comparison of integrated psycho‐oncological care versus unstructured care—Results of a non‐randomised open‐label two‐arm trial

2019

Objective To compare patients' experiences with a systematic, integrated psycho-oncological care (IC) model to experiences with "care as usual" (CAU). Methods To improve patients' knowledge about psychosocial support options and to facilitate use, an IC model was developed by psycho-oncologists and a health insurance company and implemented in one German cancer care facility. Using a parallel, non-randomised design, these patients' experiences were compared to CAU patients. In 2015, both patient groups received questionnaires 6-12 months post-inpatient treatment. Main outcomes were awareness, use and opinion of psycho-oncological care (PC) and anxiety level (Generalized Anxiety Disorder Sca…

AdultMaleHealth Knowledge Attitudes Practicemedicine.medical_specialtyPsycho-OncologyAnxietyYoung Adult03 medical and health sciences0302 clinical medicineAmbulatory careGermanyNeoplasmsSurveys and QuestionnairesmedicineHealth insuranceHumansGeneralized Anxiety Disorder ScaleAgedAged 80 and overResponse rate (survey)business.industryMiddle AgedPatient Acceptance of Health CareMental healthCare facilityOncology030220 oncology & carcinogenesisPhysical therapyAnxietyFemaleOpen labelmedicine.symptombusinessDelivery of Health CareEuropean Journal of Cancer Care
researchProduct

An exploratory, prospective, open-label trial of ingenol mebutate gel 0.05% for the treatment of external anogenital warts

2017

BACKGROUND Anogenital warts (AGW) can cause physical discomfort and decreased quality of life. Recent case reports suggest that ingenol mebutate gel might be an effective treatment of AGW. OBJECTIVE To explore primarily the safety, and secondarily the efficacy of ingenol mebutate gel 0.05% in patients with AGW. METHODS This was an exploratory, open-label, 1-arm trial of ingenol mebutate gel 0.05% administered up to three times to patients with AGW. Safety was assessed by occurrence and severity of local skin reactions (LSRs) and treatment-related adverse events (AEs). Efficacy was assessed by complete clearance and reduction in AGW count 14 days after last treatment, and recurrence 12 weeks…

AdultMaleIngenol Mebutate Gelmedicine.medical_specialtyPopulationPainAntineoplastic AgentsDermatologyYoung Adult030207 dermatology & venereal diseases03 medical and health sciencesBlister0302 clinical medicineQuality of lifeRecurrenceInternal medicineSkin UlcermedicineEdemaHumansEffective treatmentIn patientProspective Studies030212 general & internal medicineAdverse effecteducationAgedAnus Diseaseseducation.field_of_studybusiness.industryMiddle AgedSafety profileTreatment OutcomeInfectious DiseasesCondylomata AcuminataErythemaFemaleDiterpenesGenital Diseases MaleOpen labelbusinessGelsGenital Diseases FemaleJournal of the European Academy of Dermatology and Venereology
researchProduct

Glut-1 Expression and In Situ CD1a/CD57 Immunologic Deficit in Keratoacanthoma and Squamous Cell Carcinoma of Immunocompetent Patients

2011

It is not easy to reach a differential diagnosis between keratoacanthoma (KA) and squamous cell carcinoma (SCC) and furthermore there is still considerable discussion about the relationship of these 2 tumors with immunity. To facilitate such a diagnosis, we assessed the Glut-1 antibody, reported to be strongly and diffusely expressed in SCC but never assessed in KA. We studied 43 lesions of immunocompetent patients: 17 SCCs, 13 typical KAs (tKAs), and 13 atypical KAs (aKAs), with histologic features of SCC in less than 30% of the lesions. In tKA, Glut-1 stained only the basal layers of the squamous nests (basal pattern) whereas in SCC the squamous nests were randomly and diffusely stained (…

AdultMaleKeratoacanthomaPathologymedicine.medical_specialtySkin NeoplasmsHistologySettore MED/08 - Anatomia PatologicaSkin DiseasesPathology and Forensic MedicineAntigens CD1Diagnosis DifferentialBasal (phylogenetics)CD57 AntigensAntigenBiomarkers TumorCarcinomamedicineHumansAgedAged 80 and overCD20biologybusiness.industryGlut-1 Keratoacanthoma Squamous cell carcinoma CD1aImmunityMiddle Agedmedicine.diseaseKeratoacanthomastomatognathic diseasesMedical Laboratory TechnologyExcitatory Amino Acid Transporter 2Carcinoma Squamous CellDisease Progressionbiology.proteinFemaleDifferential diagnosisSkin cancerbusinessCD8Applied Immunohistochemistry & Molecular Morphology
researchProduct

Web Support for weight-loss interventions: PREDIRCAM2 clinical trial baseline characteristics and preliminary results

2018

An ongoing clinical trial is testing the efficacy of web telematic support in a structured program for obesity treatment and diabetes prevention. Participants were recruited from two tertiary-care hospitals and randomized to receive either a telematic intervention (TI) supported by PREDIRCAM2 web platform or a non-telematic intervention (NTI). All receive 1-year follow-up. Both interventions consist of tailored dietary and exercise prescriptions, based on a Mediterranean dietary pattern and general WHO exercise recommendations for adults. At 6 months, both groups have received 7 contacts, 3 exclusively telematic for the TI group. This is a preliminary result intention-to-treat analysis. One…

AdultMaleLifestyle modificationmedicine.medical_specialtyTelemedicine020205 medical informaticsMedicinaEndocrinology Diabetes and Metabolism02 engineering and technologyDiet MediterraneanBody Mass Index03 medical and health sciences0302 clinical medicineEndocrinologyLifestyle modificationDiabetes mellitusWeight Loss0202 electrical engineering electronic engineering information engineeringmedicineHumans030212 general & internal medicineHealthy LifestyleObesityExercise2. Zero hungerTelecomunicacionesbusiness.industryMiddle Agedmedicine.diseaseObesityMetabolic syndromeTelemedicine3. Good healthClinical trialMedical Laboratory TechnologyTreatment OutcomeWeight loss interventionsBaseline characteristicsPhysical therapyFemaleElectrónicaMetabolic syndromebusiness
researchProduct

Effects of resistance training on testosterone metabolism in younger and older men

2015

This study investigated the effects of resistance training (RT) on the metabolism of testosterone (T) in younger (n=5, 28±3yrs.) and older (n=8, 70±2yrs.) men. Experimental heavy resistance exercises (5×10RM leg presses) were performed before and after a 12-month of RT. No age differences were found in the production or metabolic clearance rate of T (determined by stable isotope dilution method), skeletal muscle androgen receptor content or serum LH concentrations due to acute or chronic RT. The T production capacity response to gonadotropin stimulation and the concentrations of the urinary T metabolites (androsterone and etiocholanolone) were lower in the older compared to younger men (p<0…

AdultMaleLuteinizing hormoneAgingmedicine.medical_specialtyta3111AndrosteroneBiochemistryMuscle hypertrophychemistry.chemical_compoundEndocrinologySex hormone-binding globulinInternal medicineEtiocholanoloneGeneticsmedicineHumansTestosteroneMuscle Skeletalta315ExerciseMolecular BiologyTestosteroneAgedEtiocholanoloneAndrosteronebiologyta1184Age FactorsResistance TrainingCell BiologyHypothalamic–pituitary–thyroid axisPatient Outcome AssessmentRenal EliminationAndrogen receptorEndocrinologychemistryReceptors AndrogenIsotope LabelingGnRHbiology.proteinLuteinizing hormoneHormonemedicine.drugExperimental Gerontology
researchProduct

Medial Vestibular Nucleus Lesions in Wallenberg's Syndrome Cause Decreased Activity of the Contralateral Vestibular Cortex

2005

Three patients with the clinical diagnosis of Wallenberg's syndrome caused by acute unilateral ischemic infarctions, which included the vestibular nucleus in the medullary brain stem and afferent vestibular pathways, were examined by positron emission tomography (PET) during caloric vestibular stimulation. They all had typical signs of vestibular dysfunction such as transient rotatory vertigo with vomiting at the onset, ipsiversive body and ocular lateropulsion, and a complete ocular tilt reaction with tilts of the subjective visual vertical. Compared with healthy volunteers, who show activation in a network of temporoparietal vestibular areas within both hemispheres, especially in the post…

AdultMaleMedial vestibular nucleusFunctional LateralityGeneral Biochemistry Genetics and Molecular BiologyLesionHistory and Philosophy of ScienceVestibular nucleiotorhinolaryngologic diseasesmedicineHumansLateral Medullary SyndromeCerebral CortexVestibular systemGeneral NeuroscienceCaloric theoryAnatomyMiddle AgedMagnetic Resonance ImagingVestibular cortexPositron-Emission TomographyVestibule Labyrinthsense organsmedicine.symptomVestibulo–ocular reflexPsychologyInsulaAnnals of the New York Academy of Sciences
researchProduct

Synovial sarcoma and malignant mesothelioma of the pleura: Review, differential diagnosis and possible role of apoptosis

2001

Synovial sarcoma of the pleural cavity is exceptionally rare and may be confused, both clinically and histologically, with malignant mesothelioma, with subsequent inappropriate therapy. To address this dilemma, four biphasic synovial sarcomas (BSSs) and four biphasic malignant mesotheliomas (BMMs) were studied with a panel of mucin and immunohistochemical stains to determine if they would allow one to distinguish between the two. The BMMs were all pleural-based. The BSSs were extrapleural. The mucin and immunohistochemical stains were all performed on formalin-fixed, paraffin-embedded tissue using standard techniques, with appropriate positive and negative controls. Mucin present in BSS is,…

AdultMaleMesotheliomaPathologymedicine.medical_specialtyAdolescentPleural Neoplasms2734ApoptosisPathology and Forensic MedicineNeoplasms Multiple PrimarySynovial sarcomaSarcoma SynovialPleural diseaseBiomarkers TumormedicineHumansMesotheliomaMalignant mesotheliomaAgedAged 80 and overStaining and Labelingbusiness.industryMucinApoptosis; Immunohistochemistry; Malignant mesothelioma; Synovial sarcoma; 2734MucinsApoptosiMiddle AgedPeriodic Acid-Schiff ReactionPleural cavitymedicine.diseaseImmunohistochemistrySynovial sarcomamedicine.anatomical_structureFemaleAlcian BlueSarcomaNeoplasm Recurrence LocalDifferential diagnosisCalretininbusiness
researchProduct

Assessment of Analysis of Urinary Pneumococcal Antigen by Immunochromatography for Etiologic Diagnosis of Community-Acquired Pneumonia in Adults

2006

ABSTRACT The limitations of conventional microbiologic methods (CMM) for etiologic diagnosis of community pneumococcal pneumonia have made faster diagnostic techniques necessary. Our aim was to evaluate the usefulness of the immunochromatography (ICT) technique for detecting urinary Streptococcus pneumoniae antigen in the etiologic diagnosis of community-acquired pneumonias (CAP). This was a prospective study on in-patients with CAP in a tertiary hospital conducted from October 2000 to March 2004. Apart from using CMM to reach an etiologic diagnosis, we determined pneumococcal antigen in concentrated urine by ICT. We also determined the urinary pneumococcal antigen (UPA) content in patients…

AdultMaleMicrobiology (medical)medicine.medical_specialtyAdolescentClinical BiochemistryImmunologymedicine.disease_causeCommunity-acquired pneumoniaInternal medicineStreptococcus pneumoniaemedicineHumansImmunology and AllergyProspective StudiesAgedAged 80 and overAntigens BacterialChromatographyCOPDbusiness.industryClinical and Diagnostic Laboratory ImmunologyRespiratory infectionMiddle AgedPneumonia Pneumococcalmedicine.diseaseCommunity-Acquired InfectionsPneumoniaPneumococcal infectionsStreptococcus pneumoniaePneumococcal pneumoniaImmunologyImmunologic TechniquesEtiologyFemalebusinessClinical and Vaccine Immunology
researchProduct